GlaxoSmithKline PLC (LSE:GSK) - Share price

Stock Report

GlaxoSmithKline PLC GSK

Latest Morningstar Commentary
DateAuthor Headline
24/07/2019James Gard Glaxo's Vaccines Division Outperforms
FTSE 100 dividend stalwart posts steady results in the first six months and expects better performance in the second half, during which the joint venture with Pfizer will complete
10/07/2019Emma Simon Dividend Shares to Fund My Retirement
Investor Views: Private investor Gurmit Dhendsa is running his own share portfolio rather than rely on a pension manager
08/02/2019Damien Conover GlaxoSmithKline Still Undervalued, say Analysts
FTSE 100 pharmaceutical giant has reached an inflection point, argue Morningstar analysts, moving beyond ashthma drug Advair to HIV, vaccines and consumer healthcare
29/01/2019Emma Wall Top 20 FTSE 100 Dividend Paying Stocks
THE INCOME INVESTOR: The largest companies in the UK source their revenues internationally, meaning your dividend stream is boosted by global economic growth

Latest Company News

Previous Stories...
10/07/202016:41LSEDirector/PDMR ShareholdingDSH
10/07/202015:15LSEDirector/PDMR ShareholdingDSH
10/07/202015:07LSEDirector/PDMR ShareholdingDSH
01/07/202012:25LSETotal Voting RightsTVR
29/06/202008:00LSEGSK’s daprodustat gains first regulatory approvalMSC
19/06/202015:22LSEFDA Advisory Committee review belantamab mafodotinMSC
18/06/202012:25LSEDirector/PDMR ShareholdingDSH
16/06/202012:51LSEDirector/PDMR ShareholdingDSH
11/06/202015:56LSEDirector/PDMR ShareholdingDSH
09/06/202014:16LSEDirector/PDMR ShareholdingDSH
01/06/202012:14LSETotal Voting RightsTVR
29/05/202016:41LSESecond Price Monitoring ExtnAPM
29/05/202016:37LSEPrice Monitoring ExtensionPME
26/05/202011:53LSEBlock listing Interim ReviewBLR
19/05/202017:51LSEHolding(s) in CompanyHOL
18/05/202007:09LSEViiV PrEP jab shows high efficacy over daily pillMSC
13/05/202017:04LSEDirector/PDMR ShareholdingDSH
11/05/202018:07LSEDirector/PDMR ShareholdingDSH
07/05/202017:43LSEPublication of Final TermsPFT
07/05/202015:52LSEDirector/PDMR ShareholdingDSH
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.